Back to announcement
20240502_KLBF_Laporan Informasi dan Fakta Material_31633475.pdf
Financial statement Text extracted KLBFSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 025/CSEC-KF/V-2024
Nama Perusahaan Kalbe Farma Tbk
Kode Emiten KLBF
Lampiran 3
Penyampaian Laporan Keuangan (KOREKSI)
Perihal
Mengoreksi surat kami nomor : 024/CSEC-KF/V-2024 tanggal 02 Mei 2024 perihal Penyampaian Laporan Keuangan,
dengan ini perseroan menyampaikan hal sebagai berikut:
Tahun Fiskal : 2024
Tahun Buku : MAR
Jenis Periode : Kuartal I / First Quarter
Dengan ini kami untuk dan atas nama perusahaan menyampaikan laporan keuangan, sebagai berikut:
Nama Emiten : Kalbe Farma Tbk
Bidang Usaha : Farmasi
Nilai Ekuitas : 24.111.779.621.583
Nilai Pendapatan Periode Sebelumnya : 7.869.160.883.079
Nilai Pendapatan : 8.363.028.651.272
Selisih dengan Nilai Pendapatan 493.867.768.193
:
Periode Sebelumnya
Kurs : Rupiah / IDR
Rate :
Jenis Laporan atas Laporan Keuangan : Tidak Diaudit / Unaudit
Demikian untuk diketahui.
Hormat Kami,
Kalbe Farma Tbk
Maria Teresa Fabiola
Corporate Secretary
Kalbe Farma Tbk
Gedung KALBE Let.Jend Suprato Kav. 4
Telepon : 42873888
Nama Pengirim Maria Teresa Fabiola
Page 2
Jabatan Corporate Secretary
Tanggal dan Waktu 02-05-2024 15:31
Lampiran 1. Penyampaian Laporan Keuangan Mar 2024 - E019 -.pdf
2. kalbe farma tbk_billingual_31_Mar_2024_released.pdf
3. 22-Penjelasan KLBF Liabilitas.pdf
Dokumen ini merupakan dokumen resmi Kalbe Farma Tbk yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Kalbe Farma Tbk bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 025/CSEC-KF/V-2024
Issuer Name Kalbe Farma Tbk
Issuer Code KLBF
Attachment 3
Subject Submission of Financial Report (CORRECTION)
Correction to our previous announcement number : 024/CSEC-KF/V-2024 dated 02 May 2024 with the subject of
Material Information or Facts Report , the company hereby submit the following information:
Fiscal Year : 2024
End of Year : MAR
Period Type : Kuartal I / First Quarter
The company hereby announce the Submission of Financial Report as follows:
Issuer Name : Kalbe Farma Tbk
Business Fields : Farmasi
Equity Value : 24.111.779.621.583
Previous Period Revenue : 7.869.160.883.079
Revenue : 8.363.028.651.272
Difference with Previous Period 493.867.768.193
:
Revenue
Currency : Rupiah / IDR
Rate :
Types of Reports on Financial : Tidak Diaudit / Unaudit
Thus to be informed accordingly.
Respectfully,
Kalbe Farma Tbk
Maria Teresa Fabiola
Corporate Secretary
Kalbe Farma Tbk
Gedung KALBE Let.Jend Suprato Kav. 4
Phone : 42873888
Sender Name Maria Teresa Fabiola
Function Corporate Secretary
Page 4
Date and Time 02-05-2024 15:31
Attachment 1. Penyampaian Laporan Keuangan Mar 2024 - E019 -.pdf
2. kalbe farma tbk_billingual_31_Mar_2024_released.pdf
3. 22-Penjelasan KLBF Liabilitas.pdf
This is an official document of Kalbe Farma Tbk that does not require a signature as it was generated electronically
by the electronic reporting system. Kalbe Farma Tbk is fully responsible for the information contained within this
document.
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Maria Teresa Fabiola
· Nama Pengirim
p.1 ×3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.